Admission NarxCare Narcotics Scores are not Associated With Adverse Surgical Outcomes or Self-reported Patient Satisfaction Following Elective Spine Surgery.
Adult
Elective Surgical Procedures
/ adverse effects
Female
Health Personnel
Hospitalization
Humans
Male
Middle Aged
Narcotics
/ therapeutic use
Patient Satisfaction
/ statistics & numerical data
Postoperative Period
Reoperation
Retrospective Studies
Self Report
Spine
/ surgery
Surveys and Questionnaires
Treatment Outcome
Journal
Spine
ISSN: 1528-1159
Titre abrégé: Spine (Phila Pa 1976)
Pays: United States
ID NLM: 7610646
Informations de publication
Date de publication:
01 Nov 2019
01 Nov 2019
Historique:
pubmed:
30
7
2019
medline:
16
1
2020
entrez:
30
7
2019
Statut:
ppublish
Résumé
Retrospective cohort study OBJECTIVE.: The aim of this study was to investigate how elective spine surgery patient preoperative opioid use (as determined by admission NarxCare narcotics use scores) correlated with 30-day perioperative outcomes and postoperative patient satisfaction. The effect of preoperative narcotics usage on postoperative outcomes and patient satisfaction following spine surgery has been of question. The NarxCare platform analyzes the patients' state Physician Drug Monitoring Program (PDMP) records to assign numerical scores that approximate a patient's overall opioid drug usage. Elective spine surgery cases performed at a single institution between October 2017 and March 2018 were evaluated. NarxCare narcotics use scores at the time of admission were assessed. Patient characteristics, as well as 30-day adverse events, readmissions, reoperations, and mortality, were abstracted from the medical record. Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey data were also abstracted when available.Cases were binned based on the following ranges of admission NarxCare scores: 0, 1 to 99, 100 to 299, 300 to 499, and 500+. Multivariate logistic regressions were performed to compare the odds of having an adverse events, readmission, reoperation, and mortality between the different narcotics groups. One-way analysis of variance analyses were performed to compare HCAHPS survey response rates and HCAHPS survey results between the different narcotics score groups. In total, 346 patients met criteria for inclusion in the study (NarxScore 0: n = 74, 1-99: n = 58, 300-499: n = 117, and 500+: n = 21). Multivariate logistic regressions did not detect statistically significant differential odds of experiencing adverse events, readmission, reoperation, or mortality between the different groups of admissions narcotics scores. Analyses of variance did not detect statistically significant differences in HCAHPS survey response rates, total HCAHPS scores, or HCAHP subgroup scores between the different narcotics score groups. Although there are many reasons to address preoperative patient narcotic utilization, the present study did not detect perioperative outcome differences or patient satisfaction based on the narcotic use scores as stratified here. 3.
Sections du résumé
STUDY DESIGN
METHODS
Retrospective cohort study OBJECTIVE.: The aim of this study was to investigate how elective spine surgery patient preoperative opioid use (as determined by admission NarxCare narcotics use scores) correlated with 30-day perioperative outcomes and postoperative patient satisfaction.
SUMMARY OF BACKGROUND DATA
BACKGROUND
The effect of preoperative narcotics usage on postoperative outcomes and patient satisfaction following spine surgery has been of question. The NarxCare platform analyzes the patients' state Physician Drug Monitoring Program (PDMP) records to assign numerical scores that approximate a patient's overall opioid drug usage.
METHODS
METHODS
Elective spine surgery cases performed at a single institution between October 2017 and March 2018 were evaluated. NarxCare narcotics use scores at the time of admission were assessed. Patient characteristics, as well as 30-day adverse events, readmissions, reoperations, and mortality, were abstracted from the medical record. Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey data were also abstracted when available.Cases were binned based on the following ranges of admission NarxCare scores: 0, 1 to 99, 100 to 299, 300 to 499, and 500+. Multivariate logistic regressions were performed to compare the odds of having an adverse events, readmission, reoperation, and mortality between the different narcotics groups. One-way analysis of variance analyses were performed to compare HCAHPS survey response rates and HCAHPS survey results between the different narcotics score groups.
RESULTS
RESULTS
In total, 346 patients met criteria for inclusion in the study (NarxScore 0: n = 74, 1-99: n = 58, 300-499: n = 117, and 500+: n = 21). Multivariate logistic regressions did not detect statistically significant differential odds of experiencing adverse events, readmission, reoperation, or mortality between the different groups of admissions narcotics scores. Analyses of variance did not detect statistically significant differences in HCAHPS survey response rates, total HCAHPS scores, or HCAHP subgroup scores between the different narcotics score groups.
CONCLUSION
CONCLUSIONS
Although there are many reasons to address preoperative patient narcotic utilization, the present study did not detect perioperative outcome differences or patient satisfaction based on the narcotic use scores as stratified here.
LEVEL OF EVIDENCE
METHODS
3.
Identifiants
pubmed: 31356498
doi: 10.1097/BRS.0000000000003120
pii: 00007632-201911010-00012
doi:
Substances chimiques
Narcotics
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1515-1522Références
Blendon RJ, Benson JM. The public and the opioid-abuse epidemic. N Engl J Med 2018; 378:407–411.
Luo X, Pietrobon R, Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine (Phila Pa 1976) 2004; 29:884–890. discussion 891.
Armaghani SJ, Lee DS, Bible JE, et al. Increased preoperative narcotic use and its association with postoperative complications and length of hospital stay in patients undergoing spine surgery. Clin Spine Surg 2016; 29:E93–E98.
Raad M, Jain A, Neuman BJ, et al. Association of patient-reported narcotic use with short- and long-term outcomes after adult spinal deformity surgery: multicenter study of 425 patients with 2-year follow-up. Spine (Phila Pa 1976) 2018; 43:1340–1346.
Armaghani SJ, Lee DS, Bible JE, et al. Preoperative opioid use and its association with perioperative opioid demand and postoperative opioid independence in patients undergoing spine surgery. Spine (Phila Pa 1976) 2014; 39:E1524–E1530.
Zhu H, Gao Y, Zhang C, et al. A prospective evaluation of patient-reported opioid utilization after nonoperative treatment of fractures and dislocations. J Bone Joint Surg Am 2018; 100:1177–1183.
Wang Y, Lee J, Toh MP, et al. Validity and reliability of a self-reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore. Diabet Med 2012; 29:e338–e344.
Gagne M, et al. Patient-reported outcome instruments that evaluate adherence behaviours in adults with asthma: a systematic review of measurement properties. Br J Clin Pharmacol 2018; 84:1928–1940.
Nikulina V, Guarino H, Acosta MC, et al. Patient versus provider reports of aberrant medication-taking behavior among opioid-treated chronic pain patients who report misusing opioid medication. Pain 2016; 157:1791–1798.
Jain N, Phillips FM, Weaver T, et al. Preoperative chronic opioid therapy: a risk factor for complications, readmission, continued opioid use and increased costs after one- and two-level posterior lumbar fusion. Spine (Phila Pa 1976) 2018; 43:1331–1338.
Golinvaux NS, Bohl DD, Basques BA, et al. Limitations of administrative databases in spine research: a study in obesity. Spine J 2014; 14:2923–2928.
Haut ER, Pronovost PJ, Schneider EB. Limitations of administrative databases. Jama 2012; 307:2589author reply 2589-90.
Aware P. Explain these Narx Scores. 2019 [cited 2019 February 18]; Available at: https://nevada.pmpaware.net/narx-content/content/narxcare2/explain-these-scores.pdf.
Oderda GM, Said Q, Evans RS, et al. Opioid-related adverse drug events in surgical hospitalizations: Impact on costs and length of stay. Ann Pharmacother 2007; 41:400–406.
Lee D, Armaghani S, Archer KR, et al. Preoperative opioid use as a predictor of adverse postoperative self-reported outcomes in patients undergoing spine surgery. J Bone Joint Surg 2014; 96:e89.
NarxCare. Appriss Health 2018.
Levy B, Paulozzi L, Mack KA, et al. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007-2012. Am J Prevent Med 2015; 49:409–413.
Daubs MD, Gaffney DL, Lawrence BD, et al. Long-term narcotic usage following spinal surgery. Spine J 2012; 12:S121–S122.
Soroceanu A, Ching A, Abdu W, et al. Relationship between preoperative expectations, satisfaction, and functional outcomes in patients undergoing lumbar and cervical spine surgery: a multicenter study. Spine (Phila Pa 1976) 2012; 37:E103–E108.
Deyo RA, Hallvik SE, Hildebran C, et al. Use of prescription opioids before and after an operation for chronic pain (lumbar fusion surgery). Pain 2018; 159:1147–1154.
Kelly MP, Anderson PA, Sasso RC, et al. Preoperative opioid strength may not affect outcomes of anterior cervical procedures: a post hoc analysis of 2 prospective, randomized trials. J Neurosurg 2015; 23:484–489.
Zgierska A, Miller M, Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences. Jama 2012; 307:1377–1378.
Coluzzi F, Bifulco F, Cuomo A, et al. The challenge of perioperative pain management in opioid-tolerant patients. Ther Clin Risk Manage 2017; 13:1163–1173.
Eyler ECH. Chronic and acute pain and pain management for patients in methadone maintenance treatment. Am J Addict 2013; 22:75–83.
Chapman CR, Chapman CR, Chapman CR, et al. Postoperative pain patterns in chronic pain patients: a pilot study. Pain Med 2009; 10:481–487.
Compton P, Charuvastra VC, Kintaudi K, et al. Pain responses in methadone-maintained opioid abusers. J Pain Sympt Manage 2000; 20:237–245.
Griffin D. N. C. Department of Health and Human Services Partners with Appriss Health to Provide Access to NarxCare Platform and Controlled Substances Reporting System Information Directly within Electronic Health Record and Pharmacy Management Systems, in North Carolina's Controlled Substances Reporting System Information, Advanced Analytics, Resources, and More Now Available in Clinical Workflow Via Appriss Health's PMP Gateway Integration Service for All Prescribers and Pharmacists in the State. 2018, Globe Newswire.
Griffin D., Minnesota Now Providing Appriss Health's NarxCare and PMP AWARxE to All Prescribers and Pharmacists Statewide, in Technologies to Better Assist in Clinical Decision Making and Managing Patient Care. 2018, Globe Newswire.
Griffin D., Oregon Prescription Drug Monitoring Program to be Integrated Into Electronic Health Record and Pharmacy Management Systems Statewide with Appriss Health's PMP Gateway Solution, in PMP Gateway Enables Instant Access to PDMP Information Directly in Clinical Workflow for All Prescribers and Pharmacists in Oregon. 2018, Globe Newswire. in press.
Griffin D., West Virginia Partners with Appriss Health to Enable Access to NarxCare Substance Use Disorder Platform Directly within Clinical Workflow for All Prescribers and Pharmacists State-Wide, in Powerful Analytics and Clinical Resources to Help Quickly Identify and Prevent Patient Risk and Substance Use Disorder. 2018, Globe Newswire. in press.
Griffin D., Appriss Health Partners with MDScripts to Offer Prescription Drug Monitoring Program Information and NarxCare, a Comprehensive Substance Use Disorder Platform, within Clinical Workflow, in MDScripts Providing Clinicians Access to Critical Information and Insights to Improve Patient Safety and Outcomes with Appriss Health's PMP Gateway Managed Service Platform. 2018.
Griffin D., Appriss Health and South Carolina Empower Prescribers and Pharmacists with Advanced Analytics to Improve Substance Abuse Prevention and Early Intervention, in NarxCare Provides Insights to Help Care Teams Better Identify and Treat Patients Impacted by the Opioid Crisis. 2018, Globe Newswire. in press.
Griffin D., Iowa Now Providing Appriss Health's PMP Aware and NarxCare Substance Use Disorder Platforms toAll Prescribers and Pharmacists Statewide, in PMP Aware and NarxCare to Help All Iowa Prescribers and Pharmacists Identify, Manage and Prevent Prescription Drug Misuse, Abuse and Diversion. 2018, Globe Newswire. in press.
Bovonratwet P, Bohl DD, Malpani R, et al. Cardiac complications related to spine surgery: timing, risk factors, and clinical effect. J Am Acad Orthop Surg 2019; 27:256–263.
Bovonratwet P, Webb ML, Ondeck NT, et al. Definitional differences of ’outpatient’ versus ’inpatient’ THA and TKA can affect study outcomes. Clin Orthop Relat Res 2017; 475:2917–2925.